Positron Emission Tomography Molecular Imaging of the Major Neurodegenerative Disorders: Overview and Pictorial Essay, from a Nuclear Medicine Center's Perspective

Positron Emission Tomography Molecular Imaging of the Major Neurodegenerative Disorders: Overview and Pictorial Essay, from a Nuclear Medicine Center's Perspective

Computed tomography (CT) and magnetic resonance imaging (MRI) provide key structural information on brain pathophysiology. Positron emission tomography (PET) measures metabolism in the living brain; it plays an important role in molecular neuroimaging and is rapidly expanding its field of applicatio...

Full description

Bibliographic Details
Main Authors:	Ferdinando Calabria, Mario Leporace, Andrea Cimini, Maria Ricci, Laura Travascio, Antonio Bagnato
Format:	Article
Language:	English
Published:	IMR Press 2023-12-01
Series:	Journal of Integrative Neuroscience
Subjects:	pet amyloid imaging tau protein molecular imaging neurodegenerative diseases [18f]fdopa [18f]fdg mri
Online Access:	https://www.imrpress.com/journal/JIN/22/6/10.31083/j.jin2206172

Similar Items

Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis
by: Pengbo Yu, et al.
Published: (2024-01-01)

18F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
by: Mehdi Helali, et al.
Published: (2019-01-01)

USO DE LA TOMOGRAFIA DE EMISION DE POSITRONES EN EL CANCER COLORRECTAL
by: Patricio González E, et al.

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
by: Leila Allahqoli, et al.
Published: (2023-10-01)

The role of 18F-FDG PET/CT in evaluation of Primary CNS lymphoma: The path less travelled
by: Sharjeel Usmani, et al.
Published: (2023-07-01)

Predictive value of initial involvement and early response assessment using positron‑emission tomography with 18F‑FLT in patients with non‑Hodgkin lymphoma
by: Yu. N. Likar, et al.
Published: (2014-07-01)

Predictive value of initial involvement and early response assessment using positron‑emission tomography with 18F‑FLT in patients with non‑Hodgkin lymphoma
by: Yu. N. Likar, et al.
Published: (2014-07-01)

Influence of key histological characteristics on 18F-fluorodeoxyglucose /18F-choline positron emission tomography positivity in hepatocellular carcinoma: A machine learning study
by: Jérôme Ghidaglia, et al.
Published: (2023-01-01)

Role of 18F-choline and 18F-fluorodeoxyglucose positron emission tomography in combination with magnetic resonance imaging in brachytherapy planning for locally advanced cervical cancer: A pilot study
by: Fadoua Rais, et al.
Published: (2023-07-01)

Diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography for suspected primary and postoperative pyogenic spondylitis
by: Qingyu Zhang, et al.
Published: (2023-01-01)

3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification
by: Caroline Bouillot, et al.
Published: (2023-09-01)

An updated radiosynthesis of [18F]AV1451 for tau PET imaging
by: Andrew V. Mossine, et al.
Published: (2017-06-01)

Emerging PET Tracers in Cardiac Molecular Imaging
by: Shashi Bhushan Singh, et al.
Published: (2023-01-01)

Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Susanna Nuvoli, et al.
Published: (2018-02-01)

Differential diagnosis of patients with atypical Parkinsonian syndrome using 18F-FDG and 18F-FP CIT PET: A report of five cases
by: Jang Yoo, MD, PhD, et al.
Published: (2022-08-01)

Assessment of Inflammation and Calcification in Pseudoxanthoma Elasticum Arteries and Skin with 18F-FluroDeoxyGlucose and 18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography Imaging: The GOCAPXE Trial
by: Loukman Omarjee, et al.
Published: (2020-10-01)

Infection-specific PET imaging with 18F-fluorodeoxysorbitol and 2-[18F]F-ρ-aminobenzoic acid: An extended diagnostic tool for bacterial and fungal diseases
by: Marta Rua, et al.
Published: (2023-01-01)

Physiological myocardial 18F-FDG uptake pattern in oncologic PET/CT: comparison with findings in cardiac sarcoidosis
by: Takashi Norikane, et al.
Published: (2024-01-01)

The value of 18F-FDG PET/CT imaging in breast cancer staging
by: Ulkem Yararbas, et al.
Published: (2018-02-01)

Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
by: Huan-Chun Lin, et al.
Published: (2023-05-01)

Statin Therapy and Vascular Inflammation Detected by Positron Emission Tomography/Computed Tomography in Patients with Psoriasis
by: Hannah Kaiser, et al.
Published: (2021-02-01)

Clinical Features and Diagnosis of Cardiac Sarcoidosis
by: Claudio Tana, et al.
Published: (2021-05-01)

Validation of image-derived input function using a long axial field of view PET/CT scanner for two different tracers
by: Xavier Palard-Novello, et al.
Published: (2024-03-01)

The effects of various penalty parameter values in Q.Clear algorithm for rectal cancer detection on 18F-FDG images using a BGO-based PET/CT scanner: a phantom and clinical study
by: Fatemeh Sadeghi, et al.
Published: (2023-10-01)

Editorial: Case reports in PET imaging
by: Silvia Taralli, et al.
Published: (2022-12-01)

Performance characteristics of 18F–fluorodeoxyglucose in non-infected hip replacement
by: Yiqun Wang, et al.
Published: (2023-01-01)

Does consensus contours improve robustness and accuracy on $$^{18}$$ 18 F-FDG PET imaging tumor delineation?
by: Mingzan Zhuang, et al.
Published: (2023-03-01)

Evaluation of intramural hematoma: a novel use of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging
by: Fan Yang, et al.
Published: (2024-03-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis
by: Xia Longjie, et al.
Published: (2023-07-01)

Elastofibroma Dorsi: Positron Emission Tomography/Computed Tomography Perspective
by: Tamer Aksoy
Published: (2019-09-01)

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
by: Lei Zhu, et al.
Published: (2019-04-01)

What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
by: Jules Tianyu Zhang-Yin, et al.
Published: (2022-02-01)

Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
by: Xingyu Mu, et al.
Published: (2023-12-01)

Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected
by: Fernanda Guerra Paiva, et al.
Published: (2019-02-01)

Comparison between diffusion-weighted magnetic resonance and positron-emission tomography in the evaluation of treated lymphomas with mediastinal involvement
by: Francesca Di Giuliano, et al.
Published: (2022-07-01)

Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET/CT protocol in patients with metastatic melanoma treated by immunotherapy
by: Mathieu Pavoine, et al.
Published: (2023-12-01)

Is Imaging Bacteria with PET a Realistic Option or an Illusion?
by: Shashi B. Singh, et al.
Published: (2023-03-01)

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
by: Rong Huang, et al.
Published: (2022-05-01)

Giant Polyostotic Fibrous Dysplasia: F-18-flourodeoxyglucose Positron Emission Tomography/Computerized Tomography and Radiologic Findings
by: Melis Baykara Ulusan, et al.
Published: (2020-03-01)

Molecular Imaging of Glial Tumors: Established and Emerging Tracers
by: Indraja D. Dev, et al.
Published: (2023-08-01)